PD-1 drugs for Endometrial Cancer
2 tracked PD-1 drugs in the Endometrial Cancer race. The class explanation lives on the PD-1 page; the full indication pipeline across every mechanism is on the Endometrial Cancer page.
2 approved / phase 4
Head-to-head evidence: Dostarlimab vs Pembrolizumab